Question: What effect can be observed when when ??-secretase is blocked? 
Correct Answer: APP-CTF accumulation
T 1.6553564        These data suggest that the effect of FAD mutations in PS1 on APP-CTFs accumulation was similar in presence or absence of other human components of the ??-secretase.
F 1.4186561        In vitro ??-secretase activity assays were performed as previously described [27].
F 1.4186561        In vitro ??-secretase activity assays
F 1.3614172        (A) Schematic representation of the ??-secretase purification process.
F 1.2469394        The relative amounts of AICD-Flag generated in the reactions, reflecting ??-secretase activity, were estimated by densitometry.
F 1.2469394        Therefore, it is plausible that a single mutation in PSEN1 confers different catalytic properties to distinct ??-secretase subtypes.
F 1.2469394        Taken together, these data suggest that the overexpression of the other human components of ??-secretase can influence the phenotype of FAD-linked mutations.
F 1.2469394        They further support the concept that modulating rather than inhibiting ??-secretase activity would be a more appropriate therapeutic strategy for AD [58].
F 1.2469394        For each PS1 variant, five clones were selected for a full characterization and two of them were further used for ??-secretase purification.
F 1.2469394        Finally, beads were resuspended in 50 ??L of 0.2% CHAPSO - HEPES buffer and were used for in vitro ??-secretase assays.
Sentence ErrorAnalysis for Q0: 0.1
=========================================================
========================================================
Question: When APH1 genes are overexpressed in MEF KO what happens with the A???
Correct Answer: They are longer
T 2.5877378        When compared to APH1aS or L, overexpression of APH1b in MEF knockout for all APH1 genes led to increased production of longer A?? species [24].
T 1.5083674        Indeed, ??-secretase complexes are heterogeneous in composition due to the existence of two human APH1 genes, APH1a and APH1b, and two splicing isoforms of APH1a (S and L), as well as two presenilin genes, PSEN1 and PSEN2.
Sentence ErrorAnalysis for Q1: 0.2
=========================================================
========================================================
Question: In which gene are mutations associated to many cases of early-onset familial forms of Alzheimer's disease?G
Correct Answer: PSEN1
F 1.4755745        Briefly, cells were incubated in 10 cm dishes until they reached 70% confluence and were transiently co-transfected by the calcium phosphate method, with 5 ??g of envelope plasmid (pMD2G), 15 ??g of packaging plasmid (psPAX2), and 20 ??g of vector plasmids (pSIN-PGK-WHV).
F 1.4198722        Editor: Stefano L. Sensi, University G. D'Annunzio, Italy
F 1.4198722        The washed membranes were then centrifuged at 100,000?? g for 1 h at 4??C and stored at ???80??C until use.
F 1.4198722        The supernatant was collected and centrifuged at 100,000?? g for 1 h at 4??C in a SW32
F 1.1358978        Nuclei and unbroken cells were removed by centrifugation at 3,000?? g for 20 min at 4??C in a Beckman Coulter Allegra X-15R centrifuge.
F 1.1358978        The membranes were then incubated at 4??C for 1 h. To pellet the insoluble material, the solution was centrifuged at 16,000?? g at 4??C for 1 h, the pellet was discarded, and the supernatant saved.
F 0.99391055        The beads were washed 3 times in the same buffer, and the bound proteins were eluted over 4 h at 4??C with 0.4 mL of this buffer containing 200 ??g/mL of Flag peptides (Sigma-Aldrich).
F 0.99391055        The beads were washed 3 times in the same buffer, and the bound proteins were eluted for 1 h at 4??C with 0.4 mL of this buffer containing 500 ??g/mL of V5 peptides (Sigma-Aldrich).
F 0.99391055        The beads were washed 3 times in the same buffer, and the bound proteins were eluted overnight at 4??C with 0.2 mL of this buffer containing 200 ??g/mL of HA peptides (Sigma-Aldrich).
F 0.85192335        Briefly, 100 ??g of proteins were diluted in a final volume of 1 mL of 1% CHAPSO - HEPES extraction buffer containing protease inhibitors (Roche), and 50 ??L of pre-equilibrated anti-Flag or anti-HA affinity beads (Sigma-Aldrich) were added.
Sentence ErrorAnalysis for Q2: 0.0
=========================================================
========================================================
Question: What experimental technique was used specifically to purify the ??-secretase complex?
Correct Answer: affinity chromatography
F 2.1073918        3) Solubilisation of ??-secretase complexes.
T 1.8983753        Next, these freshly prepared solubilised preparations were used for affinity purification of ??-secretase complexes as described below.
F 1.6893587        Another possible explanation would be that purified ??-secretase complexes lack binding partners modulating the processing of APP-based substrates, due to purification conditions affecting physical interactions of proteins.
F 1.5848503        As the main goal of this experiment was to compare the efficacy of the different ??-secretase complexes to process APP-based substrates, it is important to note that the final yields of the complexes purified from the different clones were very similar (Figure 4B), thus facilitating further comparative analyses.
T 1.5396017        A multi-step affinity purification procedure was used to isolate semi-purified or highly purified ??-secretase complexes.
F 1.5396017        PS1 and PS2 play fundamental roles in cell signalling as part of the ??-secretase complex.
F 1.5396017        To do so, ??-secretase complexes from the different clones were co-immunoprecipitated from microsomal extracts and their activities were assayed in vitro with the C100-His substrate.
F 1.4350936        Note that the levels of A?? produced from FAD-linked ??-secretase complexes were all in the non-linear range of the ELISA standards, close to the detection limit.
F 1.4350936        One possible explanation would be that specific subtypes of ??-secretase complexes are less affected than others by PSEN1 mutations.
F 1.4124693        High-grade purification of human ??-secretase complexes with FAD-linked PS1 mutants.
Sentence ErrorAnalysis for Q3: 0.2
=========================================================
========================================================
Question: What peptide is able to control the expression of the ApoE gene?
Correct Answer: AICD
F 0.07841888        Quantification of A?? peptidesA?? peptides from the ??-secretase assays described above were quantified by sandwich ELISA according to the protocol provided by the manufacturer.
F 0.05489322        The amyloid precursor protein (APP) is processed by the successive actions of ??-secretase (BACE1) and ??-secretase, generating amyloid-beta peptides (A??) of different lengths, ranging from 37 to 46 amino acids [10].
F 0.05489322        The beads were washed 3 times in the same buffer, and the bound proteins were eluted over 4 h at 4??C with 0.4 mL of this buffer containing 200 ??g/mL of Flag peptides (Sigma-Aldrich).
F 0.05489322        The beads were washed 3 times in the same buffer, and the bound proteins were eluted for 1 h at 4??C with 0.4 mL of this buffer containing 500 ??g/mL of V5 peptides (Sigma-Aldrich).
F 0.05489322        The beads were washed 3 times in the same buffer, and the bound proteins were eluted overnight at 4??C with 0.2 mL of this buffer containing 200 ??g/mL of HA peptides (Sigma-Aldrich).
F 0.04705133        Together with nicastrin (NCT), anterior pharynx-defective protein 1 (APH1), and presenilin enhancer 2 (PEN2), the catalytic subunit PS1 constitutes the core of the ??-secretase complex and contributes to the proteolysis of the amyloid precursor protein (APP) into amyloid-beta (A??) peptides.
F 0.04705133        WT MEF, ??-MEF and ?? - PS1/2 were transduced with an APP-based substrate corresponding to the 99 C-terminal residues of human APP fused to the APP signal peptide in N-terminus (SPA4CT [36]) and a Flag Tag in C-terminus.
F 0.04705133        WT MEF, MEF PS1/2???/??? and ?? - PS1/2 were transduced with an APP-based substrate corresponding to the 99 C-terminal residues of human APP fused to the APP signal peptide in N-terminus (SPA4CT [36]).
F 0.04147706        Different patterns of PS1 expression and autoproteolysis were observed in the different clones.
F 0.027651373        The latter cleaves numerous type-I membrane proteins in their transmembrane domain [7], releasing their corresponding intracellular domains, which are capable of influencing gene expression.
Sentence ErrorAnalysis for Q4: 0.0
=========================================================
========================================================
Question: Which amino acid is critical for the activity of the PS1 protein?
Correct Answer: aspartate
F 0.62709445        Membrane protein extracts were prepared and ??-secretase activity was assayed on an exogenous recombinant APP-based substrate consisting of the C-terminal 99 amino acid residues of APP, and referred to as C100-Flag (Figure 3A).
F 0.33335072        The amyloid precursor protein (APP) is processed by the successive actions of ??-secretase (BACE1) and ??-secretase, generating amyloid-beta peptides (A??) of different lengths, ranging from 37 to 46 amino acids [10].
T 0.24013086        Experimental evidence such as the binding of transition-state analogue ??-secretase inhibitors to PS1 [4], as well as the abolishment of ??-secretase activity when PS1 lacks the aspartate residues critical for proteolysis [4], [5], [6], have confirmed that presenilins harbour the active site of the enzymatic complex.
F 0.13454126        We also thank J.R. Alattia, C. Schweizer, and A. Alahari for critical readings of the manuscript.
F 0.080724746        Find this article online Jarrett JT, Berger EP, Lansbury PT Jr (1993) The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease.
F 0.0741815        In vitro ??-secretase activity assays were performed as previously described [27].
F 0.0741815        In vitro ??-secretase activity assays
F 0.05563612        g003 We next performed activity assays under semi-purified conditions.
F 0.05563612        The loss of activity in ??-secretase containing PS1 variants also leads to decreased generation of AICD.
T 0.053816497        MEF PS1/PS2 DKO cells (1.0??109 cells) expressing NCT-V5, Flag-PEN2, APH1aL-HA and different forms of PS1: wild type (WT), or with FAD-linked variants or lacking the critical aspartate residues, were collected from 15 cm dishes and fully resuspended in 40 mL of MES buffer (50 mM MES, pH 6.0, 150 mM NaCl, 5 mM MgCl2, 5 mM CaCl2), supplemented with protease inhibitor cocktail (Roche).
Sentence ErrorAnalysis for Q5: 0.2
=========================================================
========================================================
Question: What experimental technique was used to determine the structure of ??-secretase?
Correct Answer: EM
T 0.7014549        In particular, protocols for the high-grade purification of proteolytically active ??-secretase constituted of NCT, APH1aL, PEN2 and wild-type PS1 [26], [27] allowed the reconstitution of 3D structures at 15 ?? and 12 ?? resolution by EM and cryo-EM and gave new insights on the structure and activity of the enzyme [28], [29].
F 0.4225948        In vitro ??-secretase activity assays were performed as previously described [27].
F 0.4225948        In vitro ??-secretase activity assays
F 0.40554422        (A) Schematic representation of the ??-secretase purification process.
F 0.37144315        The relative amounts of AICD-Flag generated in the reactions, reflecting ??-secretase activity, were estimated by densitometry.
F 0.37144315        Therefore, it is plausible that a single mutation in PSEN1 confers different catalytic properties to distinct ??-secretase subtypes.
F 0.37144315        Taken together, these data suggest that the overexpression of the other human components of ??-secretase can influence the phenotype of FAD-linked mutations.
F 0.37144315        They further support the concept that modulating rather than inhibiting ??-secretase activity would be a more appropriate therapeutic strategy for AD [58].
F 0.37144315        For each PS1 variant, five clones were selected for a full characterization and two of them were further used for ??-secretase purification.
F 0.37144315        Finally, beads were resuspended in 50 ??L of 0.2% CHAPSO - HEPES buffer and were used for in vitro ??-secretase assays.
Sentence ErrorAnalysis for Q6: 0.1
=========================================================
========================================================
Question: What candidate drug that blocks the ??-secretase is now tested in clinical trials?
Correct Answer: Semagacestat
T 1.8942314        Supporting this view, the ??-secretase inhibitor Semagacestat tested in phase III clinical trials not only failed to slow cognitive decline in patients with mild-to-moderate AD, but actually made it worse [59].
F 0.31988084        In vitro ??-secretase activity assays were performed as previously described [27].
F 0.31988084        In vitro ??-secretase activity assays
F 0.30697453        (A) Schematic representation of the ??-secretase purification process.
F 0.2811619        The relative amounts of AICD-Flag generated in the reactions, reflecting ??-secretase activity, were estimated by densitometry.
F 0.2811619        Therefore, it is plausible that a single mutation in PSEN1 confers different catalytic properties to distinct ??-secretase subtypes.
F 0.2811619        Taken together, these data suggest that the overexpression of the other human components of ??-secretase can influence the phenotype of FAD-linked mutations.
F 0.2811619        They further support the concept that modulating rather than inhibiting ??-secretase activity would be a more appropriate therapeutic strategy for AD [58].
F 0.2811619        For each PS1 variant, five clones were selected for a full characterization and two of them were further used for ??-secretase purification.
F 0.2811619        Finally, beads were resuspended in 50 ??L of 0.2% CHAPSO - HEPES buffer and were used for in vitro ??-secretase assays.
Sentence ErrorAnalysis for Q7: 0.1
=========================================================
========================================================
Question: What mutation of the PS1 protein causes ??-secretase activity almost to disappear?
Correct Answer: P436Q
F 1.0997654        Our biochemical and functional findings strongly suggest that pathogenic mutations in PSEN1 cause a loss of ??-secretase activity.
T 0.93232685        Together, our results strongly support the hypothesis that the pathogenic L166P, ??E9, and P436Q mutations in PSEN1 cause a drastic loss (at least 90% as estimated by ELISA) of ??-secretase activity.
F 0.9289342        In vitro ??-secretase activity assays were performed as previously described [27].
F 0.9289342        In vitro ??-secretase activity assays
F 0.7173213        The functional characterization of these complexes revealed that all PS1 FAD-linked mutations caused a loss of ??-secretase activity phenotype, in terms of A??1???40, A??1???42 and APP intracellular domain productions in vitro.
F 0.7123738        To assess how FAD-linked mutations in PS1 affect ??-secretase activity in these purified complexes, we performed in vitro assays by using C100-Flag substrate (Figure 3A) and equal amounts of the different purified complexes, immediately after the purification to avoid freezing/thawing cycles that might affect enzymatic activity.
F 0.685613        The relative amounts of AICD-Flag generated in the reactions, reflecting ??-secretase activity, were estimated by densitometry.
F 0.685613        They further support the concept that modulating rather than inhibiting ??-secretase activity would be a more appropriate therapeutic strategy for AD [58].
F 0.685613        (B) ??-Secretase activity assays were performed with microsomal extracts prepared in 1% CHAPSO-HEPES buffer.
F 0.633602        Although a poor recovery of ??-secretase activity for the PS1-L166P and a comparatively better performance of PS1-??E9 have been reported by others under similar experimental conditions [23], the potential of PS1-P436Q mutation to restore the processing of endogenous APP-CTFs has never been assessed [34], [35].
Sentence ErrorAnalysis for Q8: 0.1
=========================================================
========================================================
Question: How many mutations relevant for familial forms of Alzheimer's disease have been detected for the PSEN1 gene?
Correct Answer: 185
F 0.81963        Mutations linked to early onset, familial forms of Alzheimer's disease (FAD) are found most frequently in PSEN1, the gene encoding presenilin-1 (PS1).
F 0.13308363        Alzheimer's Disease-Linked Mutations in Presenilin-1 Result in a Drastic Loss of Activity in Purified ??-Secretase Complexes
F 0.13308363        g005 Discussion Top Several conflicting results as to how Alzheimer's disease-linked mutations in PSEN1 affect the processing of APP by ??-secretase have been reported.
F 0.13308363        This deleterious dual effect might explain why FAD-linked PSEN1 mutations cause early onset Alzheimer's disease.
F 0.116448164        Our data support the view that PS1 mutations lead to a strong ??-secretase loss-of-function phenotype and an increased A??1???42/A??1???40 ratio, two mechanisms that are potentially involved in the pathogenesis of Alzheimer's disease.
F 0.116448164        Introduction Top Since their discovery in 1995 and their association with early onset familial Alzheimer's disease (FAD) [1], [2], the presenilin genes PSEN1 and PSEN2 have been widely studied, and the complexity of their biological role is becoming increasingly evident.
F 0.09981271        Matthias Cacquevel, Lor??ne Aeschbach, Jemila Houacine, Patrick C. Fraering*??cole Polytechnique F??d??rale de Lausanne, Brain Mind Institute, Laboratory of Molecular and Cellular Biology of Alzheimer's Disease, Lausanne, Switzerland
F 0.09981271        Find this article online Jarrett JT, Berger EP, Lansbury PT Jr (1993) The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease.
F 0.015624065        Next, the clone expressing the highest levels of all three recombinant proteins was selected (designated ?? - PS1/2) and used as the parental cell line that was further transduced with lentivectors carrying the following different human PS1 variants: PS1-WT, three dominant-negative forms of PS1 that lack the crucial, catalytic site aspartate residues (D257A, D385A, and both D257A/D385A referred to as DDAA later in the article), and three FAD-linked PS1 mutants (L166P, ??E9 and P436Q, with mean disease onset at 24 years, 45.5 years and 28.3 years, respectively).
Sentence ErrorAnalysis for Q9: 0.0
=========================================================
Sentence ErrorAnalysis for DocQA4MRE-2012_BIOMEDICAL_GS.xml_4: 0.09999999999999999
Completed 4 documents; 162799 characters
Total Time Elapsed: 4523 ms 
Initialization Time: 1219 ms
Processing Time: 3304 ms
